Overview

The Impact of Phosphate Metabolism on Healthy Aging

Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University